TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
364,661
|
852,286
|
458,510 |
| Financial expenses |
26,723
|
26,409
|
140,758 |
| Earnings before taxes |
10,966
|
30,375
|
15,605 |
| EBITDA |
15,095
|
14,039
|
-13,591 |
| Total assets |
639,714
|
401,352
|
290,942 |
| Current assets |
637,569
|
399,246
|
277,480 |
| Current liabilities |
568,183
|
305,143
|
224,938 |
| Equity capital |
68,014
|
92,754
|
64,235 |
| - share capital |
2,063
|
2,026
|
1,892 |
| Employees (average) |
16
|
14
|
14 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
10.6%
|
23.1%
|
22.1% |
| Turnover per employee |
22,791
|
60,878
|
32,751 |
| Profit as a percentage of turnover |
3.0%
|
3.6%
|
3.4% |
| Return on assets (ROA) |
5.9%
|
14.1%
|
53.7% |
| Current ratio |
112.2%
|
130.8%
|
123.4% |
| Return on equity (ROE) |
16.1%
|
32.7%
|
24.3% |
| Change turnover |
-502,993
|
361,241
|
255,255 |
| Change turnover % |
-58%
|
74%
|
126% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
14%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.